首页> 外文期刊>Indian journal of cancer. >Immunohistochemical detection of axillary lymph node micrometastases in breast cancer patients: Increasing the accuracy of detection and decreasing labor intensive serial sectioning
【24h】

Immunohistochemical detection of axillary lymph node micrometastases in breast cancer patients: Increasing the accuracy of detection and decreasing labor intensive serial sectioning

机译:免疫组化检测乳腺癌患者腋窝淋巴结微转移:提高检测准确性并减少劳动密集型连续切片

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: The histological detection of axillary lymph node tumor metastases in cases of breast carcinoma is of major prognostic significance, but may be difficult when metastases are of microscopic size. The micrometastases can be detected either by immunohistochemistry (IHC) or serial sectioning. AIMS: We investigated whether immunohistochemical techniques and serial sectioning can increase the accuracy of metastatic detection and compared the efficacy of both. MATERIALS AND METHODS: Thirty cases of breast carcinoma were studied in all of whom the axillary lymph nodes had been reported as free of metastases. Blocks from these cases were serially sectioned and stained with hematoxylin and eosin and a single section was stained with monoclonal antibody to cytokeratin AE1/AE3 and epithelial membrane antigen. The positivity for micrometastases was correlated with size, number, grade and histological type of primary tumor, lymph node size and number. RESULTS AND CONCLUSION: In 5/30 previously unsuspected cases, micrometastases were revealed by IHC and in 1/30 by serial sectioning. These findings suggested that serial sectioning is a labor intensive, time consuming and impractical procedure. Micrometastases were more frequently detected with age of patient >50 years, Grade 2/3 tumor, tumor size >5 cm and more than one primary tumor. Immunohistochemical analysis can be recommended as a routine procedure or an adjunct to routine histological procedures for the correct staging of breast carcinoma and use of adjuvant chemotherapy, especially in the high risk group.
机译:背景:乳腺癌组织中腋窝淋巴结肿瘤转移的组织学检测具有重要的预后意义,但如果转移灶为微观大小则可能很困难。可以通过免疫组织化学(IHC)或连续切片检测微转移。目的:我们调查了免疫组织化学技术和连续切片是否可以提高转移检测的准确性,并比较了两者的疗效。材料与方法:研究了30例乳腺癌患者,其中所有腋窝淋巴结均无转移。将来自这些病例的块连续切片并用苏木精和曙红染色,并将单节用针对细胞角蛋白AE1 / AE3和上皮膜抗原的单克隆抗体染色。微转移的阳性率与原发肿瘤的大小,数目,等级和组织学类型,淋巴结大小和数目相关。结果与结论:在5/30以前未曾怀疑的病例中,IHC显示了微转移,而连续切片显示了1/30。这些发现表明,连续切片是费力,费时且不切实际的过程。患者年龄> 50岁,2/3级肿瘤,肿瘤大小> 5 cm和不止一个原发肿瘤,更常发现微转移。免疫组织化学分析可建议作为常规程序或常规组织学程序的辅助手段,以正确地分期乳腺癌和辅助化疗,尤其是在高危人群中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号